Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
/in Dendritic Cells, Glioblastoma, International PublicationsRetrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer
/in Breast Cancer, Dendritic Cells, International PublicationsThe future of cellular therapy for the treatment of renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International PublicationsTrial watch: anticancer vaccination with dendritic cells
/in Dendritic Cells, International PublicationsComplete Cure of Inoperable Stage IV Locally Advanced Hypopharyngeal Squamous Cell Carcinoma by an Innovative Combination Cancer Immunotherapy Consisting of Radiation, Immune Checkpoint Inhibitors, and Dendritic Cell Vaccine
/in Dendritic Cells, International Publicationsinduction of anti‑lung cancer immune response by the A549 lung cancer stem cell lysate‑sensitized dendritic cell vaccine
/in Dendritic Cells, International Publications, NSCLCPersonalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
/in Dendritic Cells, International PublicationsCombination of Radiation Therapy, Wim’s Tumor 1 (WT1) Dendritic Cell Vaccine Therapy, and α-Galactosylceramide-Pulsed Dendritic Cell Vaccine Therapy for End-Stage Small Bowel Cancer
/in Dendritic Cells, International PublicationsPersonalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patients
/in Brain Tumors in Children, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer